✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹10,540 Cr.
P/E
35.06

Key Ratios

Market cap
Market cap
10,540 Cr
PE
PE
35.06
Prom Holding
Prom Holding
51.82 %
ROE (%)
ROE (%)
43.66
ROCE (%)
ROCE (%)
57.38
Div Yield (%)
Div Yield (%)
2.91
Sales
Sales
1,272 Cr
OPM (%)
OPM (%)
32.11 %
Debt to Equity
Debt to Equity
-

About

Procter & Gamble Health Limited, formerly known as Merck Limited, is a subsidiary of the Merck… Read more
Low
4863
52W Range
High
6739
  • Procter&Gamble Healt
  • Sanofi India
  • Strides Pharma Scien

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Drug Delivery Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Syngene International Ltd.
    • Piramal Enterprises Ltd.
    • AGI Greenpac Ltd.
    • Gulshan Polyols Ltd.
    • Empire Industries Ltd.

    FAQs on Procter & Gamble Health Ltd. Business

    Procter & Gamble Health Limited, formerly Merck Limited, is a leading healthcare company in India that expanded its operations through the acquisition of Merck's Consumer Health business in 2018.

    Procter&Gamble Healt major competitors are Sanofi India, Strides Pharma Scien, Marksans Pharma, FDC, Natco Pharma, Zota Health Care, Sequent Scientific.
    Market Cap of Procter&Gamble Healt is ₹10,533 Crs.
    While the median market cap of its peers are ₹7,980 Crs.

    Procter&Gamble Healt seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material